Recent Updates
Recently added Catalysts
FULC Positive Sentiment Score: 70/100

Fulcrum Therapeutics to Participate at the Leerink Partners Global Biopharma Conference

Tuesday, March 5, 2024 1 min read
Key Takeaway: Fulcrum Therapeutics, a clinical-stage biopharmaceutical company, has announced its participation at the Leerink Partners Global Biopharma Conference scheduled for March 13, 2024, in Miami, FL. The company will present a corporate overview and engage in one-on-one meetings with investors. This event highlights Fulcrum's focus on developing therapies for genetically defined rare diseases and provides a platform for new opportunities in funding and collaboration.

Market Sentiment Analysis

POSITIVE FACTORS

  • Fulcrum Therapeutics is presenting at a prominent biopharma conference, indicating confidence in their strategic initiatives.
  • Participation in one-on-one investor meetings suggests potential for attracting investment and partnerships.
  • The event is an opportunity for Fulcrum to showcase its commitment to addressing rare diseases.

Full Press Release Details

CAMBRIDGE, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will present a corporate overview at the Leerink Partners Global Biopharma Conference, being held in Miami, FL on Wednesday, March 13, 2024 at 9:20 a.m. ET. Management will also participate in one-on-one investor meetings.
The webcast of the presentation will be accessible here and by visiting the "Events and Presentations" section of Fulcrum Therapeutics’ website at https://ir.fulcrumtx.com/events-and-presentations. A replay of the webcast will be available on Fulcrum Therapeutics’ website for at least 30 days following the presentation.
About Fulcrum Therapeutics
LifeSci Advisors, LLC
ccalabrese@lifesciadvisors.com

Frequently Asked Questions

When will Fulcrum Therapeutics present at the Leerink Partners Conference?

Fulcrum Therapeutics will present on March 13, 2024, at 9:20 a.m. ET.

Where can I access the presentation webcast?

The webcast will be available on Fulcrum Therapeutics’ website in the Events section.

How long will the webcast replay be available?

The replay of the webcast will be accessible for at least 30 days after the presentation.

What is the focus of Fulcrum Therapeutics?

The company is focused on developing small molecules for genetically defined rare diseases.

Tags: FULC Viatris Investor Conferences Healthcare Fulcrum Therapeutics biopharmaceuticals Leerink Partners investor meetings rare diseases
Last updated: Mar 5, 2024